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INTRODUCTION

PAIN PERCEPTION AND SLEEP ARE FUNDAMENTAL PHYSIOLOGIC PROCESSES REGULATED BY OVERLAP-PING BIOLOGIC SUBSTRATES WITHIN THE CENTRAL nervous system (CNS).
Conditions associated with dysfunction of these complex systems (eg, chronic pain, insomnia, affective disturbance) are some of the most common, costly, and difficult-totreat problems facing healthcare. Longitudinal studies of chronic pain disorders indicate that exacerbations in pain are associated with disturbed sleep and that poor sleep in turn predicts increases in clinical pain. 1 Although there are many possible explanations for this reciprocal relationship, one hypothesis gaining attention in animal models is that cholinergic nuclei in the brainstem, which regulate rapid eye movement (REM) sleep, may also regulate central pain-processing mechanisms. 2 Several preliminary studies in humans have indeed found that sleep deprivation decreases pain threshold (eg, see references 3 & 4) , but these investigations did not use laboratory measures of pain that index central pain-modulatory processes. Furthermore, because sleep loss has broad physiologic and psychological effects, sleep-deprivation studies alone do not fully elucidate the sleep-pain relationship. Uncovering a significant relationship between normal interindividual variation in sleep and individual differences in central pain processing, however, would suggest a more direct functional and neurobiologic overlap of these 2 systems. Such a relationship would also raise the possibility that sleep-related parameters could serve as modifiable risk factors for vulnerability to chronic pain. To date, no studies have reported whether individual differences in slowwave sleep (SWS) or REM sleep are associated with pain perception. The aim of this brief report is to evaluate relationships between sleep architecture and pain processing in healthy women, sleeping under normal conditions.
METHODS
Adult women habitually obtaining between 7 and 8.5 hours of sleep within a stable, nocturnal, sleep phase (confirmed by 2 weeks of diaries and actigraphy), free from medical or psychiatric illnesses and centrally acting substances, were eligible. Subjects were required to be nonsmokers and low caffeine users (≤ 2 cups of coffee or equivalent per day). All subjects were enrolled in an ongoing sleep-deprivation study, which involved a 2-week washout period of any centrally acting agents (including caffeine). Data from this report were culled from the baseline phase of this larger investigation, prior to the sleep-deprivation intervention. The protocol was approved by the Institutional Review Board, and all subjects completed informed consent prior to participation. Participants underwent a standard medical history, physical exam, and laboratory blood testing (including toxicology); those with abnormal blood chemistries or testing positive for drugs were ruled out. Only pain-free nonsmokers reporting good-sleep quality (Pittsburgh Sleep Quality Index < 5), normal daytime alertness (Epworth Sleepiness Scale < 9), and minimal psychological distress (Brief Symptom Inventory Scores < 60) were eligible. Participants completed 2 consecutive days of laboratory-based sleep and pain testing, conducted in a private inpatient room. Subjects slept at their habitual bedtimes for an 8-hour period. Standard polysomnographic procedures and scoring criteria were used for sleep staging. 5 During the day, participants were prohibited from napping (monitored by actigraphy) or using centrally acting substances. Thermal pain testing was conducted at 6:00 PM; an initial orientation session was conducted prior to night 1 to familiarize participants with the equipment and procedures (data not collected). Contact heat stimuli, at non-tissue-damaging temperatures, were delivered using a peltier-element-based stimulator (medoc Advanced Medical Systems Ltd., Durham, NC), with a 9-cm 2 probe. Assessment procedures were similar to those reported previously. 6 Heat pain threshold was assessed on the ventral forearm using an ascending method of limits paradigm; from a nonpainful 32°C baseline, the temperature was steadily increased at 0.5°C per second until the subject reported pain. After heat pain threshold testing, suprathreshold thermal stimuli were delivered on the dorsal forearm to more directly assess CNS pain processing. 6 Sequences of ten 0.5-second thermal pulses were administered; all stimuli in a sequence were identical. The short interstimulus interval (2.5 seconds) produces a CNS-mediated increase in the perception of pain (temporal summation), which is widely recognized as an index of pain-related CNS excitability. 6, 7 Sequences of stimuli at 3 intensities (47°C, 49°C, 51°C) were delivered in a randomized order. We present data from the most intense sequence (51°C), as temporal summation of pain increases at higher stimulus intensities. Subjects verbally rated the painfulness of each stimulus on a 0 to 100 numeric rating scale (0="no pain", 100="most intense pain imaginable") and then rated painful aftersensations 15 seconds after the sequence. 6 Variables indexing CNS pain responsivity were average pain ratings, peak pain ratings, and ratings of painful aftersensations. 6 
RESULTS
Sixteen women (63% Caucasian; mean age=24 years, SD=4.5) participated. Table 1 presents mean data for sleep and thermal pain-testing measurements. As shown in Table 1 , a typical first-night effect was found for sleep continuity and REM-related sleep-architecture variables.
8* Analysis of individual cases for the REM-related indices found that all subjects had shorter REM latencies and all but 2 subjects had increased REM percentage on Night 2. None of the mean laboratory pain values, however, differed between days. The observed pain-testing values are consistent with previously reported values for healthy young subjects. 9 We calculated Pearson correlations between 3 standard sleep-architecture parameters [REM latency, percentage of REM sleep, and percentage of SWS] † and next-day measures of threshold and supratheshold thermal pain perception. To control for the effects of menstrual phase and oral contraceptive use (n=7), we partialed this variance out of the analyses by regressing pain variables on menstrual-cycle variables and utilizing the resultant residual scores. Additionally, we similarly adjusted suprathreshold pain measures to control for pain threshold. As shown in Table  2 , we found several robust and significant positive relationships between percentage of REM sleep for Nights 1 and 2 and suprathreshold measure or measures of respective next-day CNS pain processing (P<.05). With regard to Night 1 REM latency, we found a significant negative association with next-day ratings of painful after sensations (P=.009) and trends for mean and peak ratings (P=.059-.100). Similarly, trends for Night 2 REM latency and next-day mean and peak pain ratings were observed (P=.058-.065). With respect to SWS, percentage of SWS was inversely associated with suprathreshold pain sensitivity, but none of these relationships were significant (P<.050). Correlations between average REM latency and percentage (Nights 1 & 2) and all 3 average suprathreshold measures of pain sensitivity (Days 2-3) were significant (P=.023-.001). Of note, heat pain threshold was not significantly related to REM sleep or SWS.
DISCUSSION
This study evaluated whether individual differences in sleep architecture were associated with individual differences in thermal pain perception. We found that healthy women who initiated REM sleep sooner and/or had a greater percentage of REM sleep, rated next-day suprathreshold thermal pain more intensely, reported higher peak ratings, and experienced more-intense painful aftersensations. These novel findings extend preliminary sleepdeprivation studies and suggest that REM sleep may be intimately associated with pain-modulatory mechanisms. Intense, brief, and repetitive noxious stimuli have been shown in animal models to increase nociceptive transmission in the dorsal horn. 7 In humans, heightened peak ratings and painful aftersensations are thought to reflect these same supraspinally mediated pain-facilitatory processes. 6, 7 This central sensitization has been implicated in the etiology of several chronic pain conditions, including fibromyalgia 6 and temporomandibular joint disorders. 10 With respect to the REM findings, reductions in REM latency and increases in REM sleep have been hypothesized to reflect central abnormalities in monoaminergic and cholinergic tone and are heritable traits associated with risk and relapse in unipolar depression. 11 Because subjects in this study who reported current depressive symptoms, a history of recurrent depression, or a depressive episode within the past 6 months were excluded from participation, individuals with shorter REM latencies in this investigation are likely to reflect normal individual variation in REM expression. An important direction for future research will be to determine whether these individuals are at increased risk for developing chronic pain conditions as well as depression. Our finding that pain sensitivity did not change in association with first-night effect changes in sleep architecture is consistent with a trait interpretation of the REM data, ie, increased REM-sleep expressors may have heightened central sensitivity to pain. The somewhat stronger associations found between Night 1 REM sleep and next-day pain sensitivity require further study and suggest that the true magnitude of relationship between stable REM sleep and pain may be less robust. Caution should be noted in the interpretation of these preliminary findings, due to the small sample size and the possibility that some of the associations may have occurred by chance. It also remains possible, given a larger sample, that an inverse relationship between SWS and pain might be detected. These limitations notwithstanding, the findings are consistent with animal studies showing that cholinergic pontine nuclei, which regulate REM sleep, influence nociception 2 and suggest a common biologic substrate that may account for the high comorbidity between chronic pain, affective dysfunction, and sleep disorders. Replication and extension of these relationships in larger prospective studies are needed, as are investigations designed to determine whether variations in REM sleep are risk factors for chronic pain. Suprathreshold variables are corrected for use of oral contraceptives, menstrual cycle phase, and heat pain threshold. *Average rating of pain intensity (0-100) for 10, 51° C, .5 second heat pulses presented with an interstimuli interval of 2.5 seconds. †Highest pain intensity rating for 10, 51° C, .5 second heat pulses presented with an interstimuli interval of 2.5 seconds. ‡Heat Pain Intensity Ratings at site of room temperature thermode, 15 seconds after final train of 10, 51° C heat pulses were presented P values ≤ . 10 † Rating of pain intensity (0-100) on a numeric rating scale for 10 consecutive, 51°C, .5-second, heat pulses presented with an interstimulus interval of 2.5 seconds. ‡Highest pain intensity rating for the 10 consecutive, 51°C, .5-second, heat pulses presented with an interstimulus interval of 2.5 seconds. §Heat pain intensity ratings at site of room-temperature thermode, 15 seconds after presentation of the final heat pulse in the train of 10 consecutive, 51°C pulses. search Center M01-RR-02719
